https://www.selleckchem.com/pr....oducts/3-3-cgamp.htm
Fibrinolysis remains the primary reperfusion strategy for ST-elevation myocardial infarction (STEMI) in many Asian countries. The outcomes and factors affecting mortality in STEMI fibrinolysis in the Asian population are lacking despite being widely used. This study aimed to assess the clinical profile of patients and predictors affecting STEMI mortality in an Asian population. This single-center retrospective study analyzed data from STEMI patients who received fibrinolytic therapy from 2016 to 2020 in a tertiary hospital. Logistic r